Cargando…

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results

Bacterial infections causing acute exacerbations of chronic obstructive pulmonary disease (AECOPD) frequently require antibacterial treatment. More evidence is needed to guide antibiotic choice. The Moxifloxacin in Acute Exacerbations of Chronic Bronchitis TriaL (MAESTRAL) was a multiregional, rando...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, Robert, Anzueto, Antonio, Miravitlles, Marc, Arvis, Pierre, Alder, Jeff, Haverstock, Daniel, Trajanovic, Mila, Sethi, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393767/ https://www.ncbi.nlm.nih.gov/pubmed/22135277 http://dx.doi.org/10.1183/09031936.00090311

Ejemplares similares

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology
por: Wilson, Robert, et al.
Publicado: (2011)

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
por: Wilson, Robert, et al.
Publicado: (2015)

Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease
por: Sethi, S., et al.
Publicado: (2015)

“Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27.
Publicado: (2012)

Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study
por: Schaper, N. C., et al.
Publicado: (2012)

A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections
por: Gyssens, Inge C., et al.
Publicado: (2011)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients
por: Bagge, Kristian, et al.
Publicado: (2021)

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014)

Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient Therapy
por: Veeraraghavan, Balaji, et al.
Publicado: (2020)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

Myoclonus induced by amoxicillin-clavulanic acid
por: Viloria-Alebesque, Alejandro, et al.
Publicado: (2020)

Amoxicillin-Clavulanate-Induced Ischaemic Colitis
por: Alonge, Marco, et al.
Publicado: (2020)

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010)

Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
por: Sethi, Sanjay, et al.
Publicado: (2010)

Is the standard dose of amoxicillin-clavulanic acid sufficient?
por: Haeseker, Michiel, et al.
Publicado: (2014)

Drug Induced Autoimmune Hepatitis by Amoxicillin-Clavulanate
por: BARIŞ KUZU, Ufuk, et al.
Publicado: (2016)

Kounis syndrome associated with amoxicillin/clavulanic acid
por: Shimi, A, et al.
Publicado: (2016)

Evaluation of urine concentrations of amoxicillin and clavulanate in cats
por: KuKanich, Kate, et al.
Publicado: (2020)

Comparative trial between the use of amoxicillin and amoxicillin clavulanate in the removal of third molars
por: Iglesias-Martín, Fernando, et al.
Publicado: (2014)

Treatment of Cervical Chlamydial Infection With Amoxicillin/Clavulanate Potassium
por: Mann, Melinda S., et al.
Publicado: (1993)

Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
por: Lee, Soo-Yun, et al.
Publicado: (2015)

Amoxicillin/clavulanic acid-induced pancreatitis: case report
por: Chams, Sana, et al.
Publicado: (2018)

672. The Impact on Humans of Treating Dogs with Amoxicillin/Clavulanate
por: Beaulac, Kirthana R, et al.
Publicado: (2018)

Drug-Induced Liver Injury Caused by Amoxicillin/Clavulanate
por: Ferreira, Inês, et al.
Publicado: (2020)

Amoxicillin/clavulanic acid: Aseptic meningitis: case report
Publicado: (2021)

Sales of macrolides, lincosamides, streptogramins, and amoxicillin/clavulanate in the in- and outpatient setting in 10 European countries, 2007–2010
por: Ferrer, Pili, et al.
Publicado: (2015)

The utility of the basophil activation test in the diagnosis of immediate amoxicillin or amoxicillin-clavulanate hypersensitivity in children and adults
por: Barni, Simona, et al.
Publicado: (2017)

Acute warfarin toxicity: An unanticipated consequence of amoxicillin/clavulanate administration
por: Larsen, Timothy R., et al.
Publicado: (2014)

HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity
por: Stephens, Camilla, et al.
Publicado: (2013)

Suitability of Amoxicillin–Clavulanic Acid for Administration via Prolonged Infusion
por: Fawaz, Sarah, et al.
Publicado: (2020)

Severe Case of Cholestatic Hepatitis From Amoxicillin/Clavulanic Acid
por: Goyal, Lokesh, et al.
Publicado: (2022)

Amoxicillin-Clavulanate Induced Liver Injury in a Young Female
por: Appiah, Jennifer, et al.
Publicado: (2023)

Inclusion of clavulanic acid determinants in the basophil activation test improves the evaluation of immediate reactions to amoxicillin-clavulanic acid
por: Fernandez, Tahia D, et al.
Publicado: (2014)

Moxifloxacin in the Outpatient Treatment of Moderate Exacerbations of Chronic Obstructive Pulmonary Disease
por: Minov, Jordan, et al.
Publicado: (2018)

Correction: HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity
Publicado: (2014)

High-Dose Amoxicillin with Clavulanate for the Treatment of Acute Otitis Media in Children
por: Chu, Chia-Huei, et al.
Publicado: (2014)

Amoxicillin-clavulanate-induced Granulomatous Hepatitis: Case Report and Review of the Literature
por: Aggarwal, Avin, et al.
Publicado: (2019)

Comparison of sensitivity of bacteria isolated in odontogenic infections to ceftriaxone and amoxicillin-clavulanate
por: Adamson, Olawale Olatunbosun, et al.
Publicado: (2019)

Amoxicillin-clavulanate induced DRESS syndrome masquerading as red man syndrome
por: Jafry, Ali H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_66l8ernk018lh0dop16p4n14cl